terfenadine has been researched along with 2019 Novel Coronavirus Disease in 2 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hassan, K | 1 |
| Dannhorn, A | 1 |
| Ling, S | 1 |
| Powell, S | 1 |
| McCall, E | 1 |
| Maglennon, G | 1 |
| Jones, GN | 1 |
| Pierce, AJ | 1 |
| Strittmatter, N | 1 |
| Hamm, G | 1 |
| Barry, ST | 1 |
| Bunch, J | 1 |
| Goodwin, RJA | 1 |
| Takats, Z | 1 |
2 other studies available for terfenadine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Urticaria and angioedema as a prodromal cutaneous manifestation of SARS-CoV-2 (COVID-19) infection.
Topics: Angioedema; Anti-Allergic Agents; Betacoronavirus; Chlorpheniramine; Coronavirus Infections; COVID-1 | 2020 |
Evaluation of UV-C Decontamination of Clinical Tissue Sections for Spatially Resolved Analysis by Mass Spectrometry Imaging (MSI).
Topics: Animals; Azetidines; COVID-19; Decontamination; Head and Neck Neoplasms; Humans; Male; Metabolome; N | 2021 |